Update: 07.12.2021
Last week: 47th week 2021
Last full month: Oct 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | ||||||||
| WoW | 1 717 | -3.5% | 44.4% | -2.3 | 750 643 | -4.2% | 74.8% | -1.8 |
| MoM | 9 836 | 8.9% | 52.7% | -1.3 | 4 274 998 | 16.8% | 80.5% | 0.1 |
| YTD | 108 975 | -23.6% | 56.6% | -5.2 | 41 840 428 | 0.5% | 80.6% | 0.2 |
| MAT | 122 917 | -23.0% | 57.0% | -4.4 | 46 468 711 | 0.2% | 80.8% | 0.6 |
| CAPSICAM | ||||||||
| WoW | 21 857 | 1.1% | 3.7% | 0.2 | 8 836 944 | 1.4% | 3.9% | 0.2 |
| MoM | 98 655 | 11.0% | 3.3% | 0 | 39 872 483 | 9.4% | 3.5% | 0.1 |
| YTD | 946 010 | -20.3% | 3.2% | -0.3 | 390 531 121 | -5.5% | 3.5% | -0.2 |
| MAT | 1 086 690 | -19.6% | 3.3% | -0.3 | 448 787 238 | -3.2% | 3.6% | -0.1 |
| MILDRONATE | ||||||||
| WoW | 100 978 | -3.6% | 86.9% | -0.3 | 38 966 933 | -2.6% | 90.1% | -0.1 |
| MoM | 475 089 | 22.1% | 86.9% | 2 | 182 644 369 | 20.2% | 89.7% | 1.6 |
| YTD | 4 329 120 | 14.1% | 63.9% | 0.3 | 1 752 077 412 | 21.4% | 68.8% | 1.5 |
| MAT | 4 816 674 | 14.6% | 63.6% | 0.2 | 1 960 335 677 | 23.2% | 68.6% | 1.6 |
| SULFARGIN | ||||||||
| WoW | 2 808 | 3.8% | 0.8% | 0.1 | 1 414 326 | 4.1% | 1.2% | 0.1 |
| MoM | 13 526 | 3.1% | 0.8% | 0 | 6 782 685 | 2.8% | 1.2% | -0.1 |
| YTD | 144 824 | -24.5% | 0.8% | -0.2 | 70 413 899 | -10.8% | 1.2% | -0.1 |
| MAT | 162 489 | -21.7% | 0.8% | -0.2 | 78 606 657 | -7.5% | 1.2% | -0.1 |
| VIPROSAL | ||||||||
| WoW | 28 801 | -13.9% | 4.9% | -0.6 | 10 994 012 | -14.2% | 4.8% | -0.6 |
| MoM | 143 156 | 17.7% | 4.8% | 0.3 | 53 773 094 | 18.7% | 4.8% | 0.5 |
| YTD | 1 090 260 | -15.3% | 3.7% | -0.1 | 410 579 270 | -5.2% | 3.7% | -0.2 |
| MAT | 1 228 004 | -15.0% | 3.7% | -0.1 | 463 761 579 | -3.1% | 3.7% | -0.1 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 1 717 | -3.5% | 44.4% | -2.3 | 750 643 | -4.2% | 74.8% | -1.8 |
| CAPSICAM | 21 857 | 1.1% | 3.7% | 0.2 | 8 836 944 | 1.4% | 3.9% | 0.2 |
| MILDRONATE | 100 978 | -3.6% | 86.9% | -0.3 | 38 966 933 | -2.6% | 90.1% | -0.1 |
| SULFARGIN | 2 808 | 3.8% | 0.8% | 0.1 | 1 414 326 | 4.1% | 1.2% | 0.1 |
| VIPROSAL | 28 801 | -13.9% | 4.9% | -0.6 | 10 994 012 | -14.2% | 4.8% | -0.6 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 9 836 | 8.9% | 52.7% | -1.3 | 4 274 998 | 16.8% | 80.5% | 0.1 |
| CAPSICAM | 98 655 | 11.0% | 3.3% | 0 | 39 872 483 | 9.4% | 3.5% | 0.1 |
| MILDRONATE | 475 089 | 22.1% | 86.9% | 2 | 182 644 369 | 20.2% | 89.7% | 1.6 |
| SULFARGIN | 13 526 | 3.1% | 0.8% | 0 | 6 782 685 | 2.8% | 1.2% | -0.1 |
| VIPROSAL | 143 156 | 17.7% | 4.8% | 0.3 | 53 773 094 | 18.7% | 4.8% | 0.5 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 108 975 | -23.6% | 56.6% | -5.2 | 41 840 428 | 0.5% | 80.6% | 0.2 |
| CAPSICAM | 946 010 | -20.3% | 3.2% | -0.3 | 390 531 121 | -5.5% | 3.5% | -0.2 |
| MILDRONATE | 4 329 120 | 14.1% | 63.9% | 0.3 | 1 752 077 412 | 21.4% | 68.8% | 1.5 |
| SULFARGIN | 144 824 | -24.5% | 0.8% | -0.2 | 70 413 899 | -10.8% | 1.2% | -0.1 |
| VIPROSAL | 1 090 260 | -15.3% | 3.7% | -0.1 | 410 579 270 | -5.2% | 3.7% | -0.2 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 122 917 | -23.0% | 57.0% | -4.4 | 46 468 711 | 0.2% | 80.8% | 0.6 |
| CAPSICAM | 1 086 690 | -19.6% | 3.3% | -0.3 | 448 787 238 | -3.2% | 3.6% | -0.1 |
| MILDRONATE | 4 816 674 | 14.6% | 63.6% | 0.2 | 1 960 335 677 | 23.2% | 68.6% | 1.6 |
| SULFARGIN | 162 489 | -21.7% | 0.8% | -0.2 | 78 606 657 | -7.5% | 1.2% | -0.1 |
| VIPROSAL | 1 228 004 | -15.0% | 3.7% | -0.1 | 463 761 579 | -3.1% | 3.7% | -0.1 |
## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"